Al Benson, MD
Enriched profileProfessor of Medicine, Division of Hematology and Oncology; Director for Cooperative Groups · Northwestern University Feinberg School of Medicine
Al Benson is Professor of Medicine, Division of Hematology and Oncology; Director for Cooperative Groups at Northwestern University Feinberg School of Medicine. OpenAlex indexes 811 publications with 74,238 citations (h-index 132); ClinicalTrials.gov lists 16 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Medical Oncology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 14 Oct 2026
Al B. Benson III, MD, is Professor of Medicine, Division of Hematology and Oncology at Northwestern University Feinberg School of Medicine / Robert H. Lurie Comprehensive Cancer Center. The public record shows 811 publications with 74,238 citations (h-index 132), centered on Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes, Colorectal Cancer Surgical Treatments. It also documents an investigator role on 16 registered clinical trials, industry payments reported by 32 companies, 8 NIH-funded awards (1987–2026).
- Most recent indexed publication: 2026 · The oncologist
- Top research focus: Colorectal Cancer Treatments and Studies
- 16 registered trials on ClinicalTrials.gov
- Open Payments reporting from 32 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 28 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 408.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 16 registered studies on ClinicalTrials.gov. The most recent:
- FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma
Sponsor: Al B. Benson, III, MD
Industry payments
Updated 14 Oct 2026
32 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20251 payment$12,500openpaymentsdata.cms.gov ↗
- GENZYME CORPORATIONProgram year20252 payments
- Corcept TherapeuticsProgram year20253 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
64.6%PD-1 inhibitor32%Nivolumab100%Part B, office-administered≥18 patientsCD38-directed Cytolytic Antibody29.6%Daratumumab100%Part B, office-administered≥25 patients+ 2 more classes in this area
Dermatology
14.2%Corticosteroid14.2%Methylprednisolone sodium succinate100%Part B, office-administered≥21 patientsMetabolism & gastrointestinal
10.3%Other antiemetics9%Fosaprepitant100%Part B, office-administered≥12 patientsSerotonin-3 Receptor Antagonist1.2%Palonosetron hcl100%Part B, office-administered≥24 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
8 NIH research awards on record, funded 1987–2026 per NIH RePORTER. The latest:
- Northwestern University Lead Academic Participating Site
Northwestern University
FY2026$1,492,954UG1CA308665 - Northwestern University Lead Academic Participating Site
Northwestern University
FY2025$463,643UG1CA233320
Congress activity
Updated 14 Oct 2026
160 congress contributions (2003–2025) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
- Care delivery and biomarker testing for people with colorectal cancer receiving 4R care sequence plans.
ASCO Annual Meeting
ASCO2025Co-author - Clinical and molecular outcomes of gastrointestinal malignancies treated with early phase studies: A retrospective single-center experience.
ASCO Annual Meeting
ASCO2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Gastrointestinal malignancies in pregnancy: practical considerations.
Journal of gastrointestinal oncology
Comment2026 - NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal.
Journal of clinical oncology
Clinical Trial2026 - A Phase III study of perioperative dostarlimab in patients with dMMR/MSI-H resectable colon cancer: AZUR-2 study design.
Future oncology (London, England)
Article2026
Most-cited works
by citation count (OpenAlex)- 01ESMO consensus guidelines for the management of patients with metastatic colorectal cancerArticle3,468 citations2016
- 02Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine TumorsArticle3,215 citations2017
- 03
- 04Hepatobiliary CancersArticle2,272 citations2009
- 05
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/al-benson-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- X / Twitter
x.com/LurieCancer/status/1754597557223727325
- YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nm.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nm.org ↗
- FACP - Fellow
American College of Physicians
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.northwestern.edu ↗ - FASCO - Fellow
American Society of Clinical Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.northwestern.edu ↗
Editorial & leadership roles
journal and society appointments- Chair
NCCN Hepatobiliary Guidelines Panel
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.northwestern.edu ↗ - Chair
NCCN Colon, Rectal and Anal Panel
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.northwestern.edu ↗ - Executive Committee Member and past-Chair
Board of Directors, National Comprehensive Cancer Network (NCCN)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.northwestern.edu ↗ - Deputy Chair for Policy and Implementation
ECOG-ACRIN Research Group
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.northwestern.edu ↗ - Chair
International Rare Cancers Initiative (IRCI) Anal Cancers Committee
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cancer.northwestern.edu ↗ - Past President
International Society of Gastrointestinal Oncology (ISGIO)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →openaccessgovernment.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.northwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.northwestern.edu ↗
Secondary affiliations
appointments beyond the home institution- Big Ten Cancer Research Consortium - past Chair
Steering Committee and GI Working Group
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →openaccessgovernment.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Clyde Yancy, MD
Northwestern University Feinberg School of Medicine
Martin Tallman, MD
Northwestern University Feinberg School of Medicine
Sanjiv Shah, MD
Northwestern University Feinberg School of Medicine
Philip Gorelick, MD
Northwestern University Feinberg School of Medicine
Eric Van Cutsem, MD, PhD
University Hospitals Leuven (UZ Leuven)
Josep Tabernero, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Charles Fuchs, MD, MPH
Tubulis GmbH